EMA Write PMS API Implementation Guide - Enrichments
1.2.2 - release

EMA Write PMS API Implementation Guide - Enrichments - Local Development build (v1.2.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Examples
... 3 Artifacts Summary
.... 3.1 EMA Write API ActivityDefinition
.... 3.2 EMA Write API ActivityDefinition Restrictions
.... 3.3 EMA Write API Marketing Regulated Authorization
.... 3.4 EMA Write API MedicinalProductDefinition
.... 3.5 EMA Write API MedicinalProductDefinition Restrictions
.... 3.6 EMA Write API PackagedProductDefinition
.... 3.7 EMA Write API PackagedProductDefinition
.... 3.8 EMA Write API Regulated Authorization
.... 3.9 EMA Write PMS API Bundle
.... 3.10 EMA Write PMS API Bundle Restrictions
.... 3.11 EMA AdditionalMonitoringIndicator boolean CodeableConcept
.... 3.12 EMA API V2 Identifier
.... 3.13 EMA Application Identifier Number
.... 3.14 EMA ATC Coding
.... 3.15 EMA Coding
.... 3.16 EMA Coding Restrictions
.... 3.17 EMA Duration
.... 3.18 EMA Eudra GMP Number Identifier
.... 3.19 EMA EURD Identifier
.... 3.20 EMA Generic ReferentialTerm CodeableConcept
.... 3.21 EMA Generic ReferentialTerm CodeableConcept restrictions
.... 3.22 EMA Generic ReferentialTerm CodeableConcept restrictions (extension allowed)
.... 3.23 EMA Genetically Modified Organisms CodeableConcept
.... 3.24 EMA Identifier Restrictions
.... 3.25 EMA Legal Basis CodeableConcept
.... 3.26 EMA Light ATC CodeableConcept
.... 3.27 EMA Manufacturing Authorization Number Identifier
.... 3.28 EMA Marketing Authorization Identifier
.... 3.29 EMA Master File Identifier
.... 3.30 EMA Master File Identifier Restrictions
.... 3.31 EMA Master Identifier
.... 3.32 EMA MP Identifier
.... 3.33 EMA National Classification Coding
.... 3.34 EMA Orphan Designation Number Identifier
.... 3.35 EMA PC Identifier
.... 3.36 EMA Period
.... 3.37 EMA Period restrictions
.... 3.38 EMA Pharmacovigilance Qualified Person Type CodeableConcept
.... 3.39 EMA Pharmacovigilance Qualified Person Type CodeableConcept
.... 3.40 EMA Product Category CodeableConcept
.... 3.41 EMA Quantity
.... 3.42 EMA Ratio
.... 3.43 EMA Ratio
.... 3.44 EMA Reference Restrictions
.... 3.45 EMA xEVMPD Identifier
.... 3.46 EMA XEVMPD Product CodeableConcept
.... 3.47 The MPD Name Part Type Coding
.... 3.48 Authorised Dose Form
.... 3.49 Code System Name
.... 3.50 Date of Update extension
.... 3.51 Language
.... 3.52 MedicinalProductDefiniton - MasterFile
.... 3.53 Reason
.... 3.54 Regulated Authorization - Date of First Authorisation
.... 3.55 Regulated Authorization - International Birth Date
.... 3.56 Regulated Authorization - Paediatric - Reference Country
.... 3.57 Risk of Supply Shortage
.... 3.58 Risk of Supply Shortage Comment
.... 3.59 String Repeat
.... 3.60 Submission Date extension
.... 3.61 Term Version
.... 3.62 The ATC Pending Extension
.... 3.63 The Comparator Extension
.... 3.64 The Complies with directive Extension
.... 3.65 The Ingredient Annex 5.10 Extension
.... 3.66 The Ingredient Annex 5.11 Extension
.... 3.67 The Ingredient Annex 5.20 Extension
.... 3.68 The Ingredient Annex 5.23 Extension
.... 3.69 The Ingredient Documentation Extension
.... 3.70 The Ingredient's Origin of Substance Extension
.... 3.71 The Intended Effect Extension
.... 3.72 The Operation Extension
.... 3.73 The Package Shelf Life Duration Extension
.... 3.74 Additional Monitoring Indicator
.... 3.75 Application Submission Type
.... 3.76 Authorised Dose Form
.... 3.77 Combined Pharmaceutical Dose Form
.... 3.78 Country
.... 3.79 Country Grouping
.... 3.80 Data Classification
.... 3.81 Documentation
.... 3.82 Domain
.... 3.83 Genetically Modified Organism
.... 3.84 Ingredient Role
.... 3.85 Language
.... 3.86 Legal Status of Supply
.... 3.87 Manufacturing Activity
.... 3.88 Marketing and Manufacturing types
.... 3.89 Marketing Status
.... 3.90 Marketing Status Reason
.... 3.91 Master File Identifier Type
.... 3.92 Master File Type
.... 3.93 Master File Type + DocumentType
.... 3.94 Material
.... 3.95 Medical Dictionary For Regulatory Activities
.... 3.96 Medicinal Product Name Part Type
.... 3.97 Medicinal Product Type
.... 3.98 Medicine Profile
.... 3.99 Packaging
.... 3.100 Paediatric Use Indicator
.... 3.101 Pharmaceutical Dose Form
.... 3.102 Product Category
.... 3.103 Product Cross Reference Type
.... 3.104 Promotion
.... 3.105 Quantity Operator
.... 3.106 Record Status
.... 3.107 Regulatory Authorization Registration Procedure
.... 3.108 Regulatory Entitlement Status
.... 3.109 Regulatory Entitlement Type
.... 3.110 Shelf Life Type
.... 3.111 Special Precautions For Storage
.... 3.112 Substance Origin
.... 3.113 Supply
.... 3.114 Target Species
.... 3.115 Unit of Measurement
.... 3.116 Units of Presentation
.... 3.117 XEVMPD medicinal product type
.... 3.118 XEVMPD medicinal product type
.... 3.119 Accuracy of Number of Animals
.... 3.120 Additional Monitoring Indicator
.... 3.121 Application Submission Type
.... 3.122 Combination Package
.... 3.123 Combined Pharmaceutical Dose Form
.... 3.124 Combined Term
.... 3.125 Contact Type
.... 3.126 Country
.... 3.127 Country Grouping
.... 3.128 Data Classification
.... 3.129 Document Type
.... 3.130 Documentation
.... 3.131 Domain
.... 3.132 Genetically Modified Organism
.... 3.133 Ingredient Role
.... 3.134 Language
.... 3.135 Legal Status From the Supply
.... 3.136 Manufacturing Activity Value Set
.... 3.137 Marketing Authorisation Application Legal Basis
.... 3.138 Marketing Status
.... 3.139 Master File Identifier Type
.... 3.140 Master File Type
.... 3.141 Material
.... 3.142 Medical Dictionary For Regulatory Activities Code System
.... 3.143 Medicinal Product Name Part Type
.... 3.144 Medicinal Product Type
.... 3.145 Medicine Profile
.... 3.146 Packaging
.... 3.147 Paediatric Use Indicator
.... 3.148 Pharmaceutical Dose Form
.... 3.149 Product Category
.... 3.150 Product Cross Reference Type
.... 3.151 Promotion
.... 3.152 Quantity Operator
.... 3.153 Reason for Marketing Unavailability
.... 3.154 Record Status
.... 3.155 Regulatory Authorization Registration Procedure
.... 3.156 Regulatory Entitlement
.... 3.157 Regulatory Entitlement Status
.... 3.158 Routes and Methods Of Administration
.... 3.159 Shelf Life Type
.... 3.160 Special Precautions for Storage
.... 3.161 Substance Origin
.... 3.162 Supply
.... 3.163 Unit Of Measurement Value Set
.... 3.164 Units Of Presentation
.... 3.165 XEVMPD Medicinal Product Type
.... 3.166 1. Get Product Bundle
.... 3.167 2. Change pack size
.... 3.168 3. Change pack size (response)
.... 3.169 4. Add manufacturing operation
.... 3.170 5. Add manufacturing operation (response)
.... 3.171 ActivityDefinition
.... 3.172 DocumentReference
.... 3.173 DocumentReference
.... 3.174 Organization
.... 3.175 PractitionerRole